GENELABS TECHNOLOGIES, INC.

Company Information

Company Name
GENELABS TECHNOLOGIES, INC.
Address
505 PENOBSCOT DRIVE
Redwood City, CA, 94063
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$702,170.00
11
SBIR Phase II
$2,520,228.00
5
Chart code to be here

Award List

  1. "STUDY OF LINKED GROWTH FACTOR GENES ON CHROMOSOME 5"

    Amount: $500,000.00

    WE PROPOSE TO ISOLATE NEW GROWTH FACTOR OR GROWTH FACTOR RECEPTOR GENES, BASED UPON THEIR LINKAGE TO A CLUSTER OF SUCH GENES ON HUMAN CHROMOSOME 5. A LONG RANGE COMPARATIVE PHYSICAL MAP OF THE KNOWN G ...

    SBIR Phase II 1991 Department of Health and Human Services
  2. HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

    Amount: $500,000.00

    THE HUMAN IMMUNE RESPONSE IS GOVERNED BY ORDERED INTERACTIONS BETWEEN FUNCTIONALLY AND PHENOTYPICALLY DISTINCT LYMPOID CELLS (T CELLS AND THEIR SUBSETS, B CELLS) AND MONOCYTES IN THE CONTEXT OF IA-LIK ...

    SBIR Phase II 1986 Department of Health and Human Services
  3. IDENTIFICATION AND ISOLATION OF THE CYSTIC FIBROSIS GENE

    Amount: $50,000.00

    COMPLETE AND PARTIAL RESTRICTION-ENZYME DIGESTS OF GENOMIC DNA WILL BE ANALYZED BY PFGE TO MAP THE KNOWN DNA MARKERS LINKED TO THE GENE FOR CYSTIC FIBROSIS. THESE TECHNIQUES WILL BE USED TO IDENTIFY L ...

    SBIR Phase I 1987 Department of Health and Human Services
  4. INHIBITORS OF INTERLEUKIN

    Amount: $500,000.00

    THIS RESEARCH WILL IDENTIFY AND CLONE ENDOGENOUS INHIBITORY MOLECULES OF INTERLEUKIN-1 (IL-1). HUMAN IMMUNODEFICIENCY VIRUS (HIV)-INFECTED MACROPHAGES AND MACROPHAGE CELL LINES RELEASE TWO INHIBITORS ...

    SBIR Phase II 1991 Department of Health and Human Services
  5. A NOVEL ASSAY FOR THE DETECTION OF ANTIVIRAL DRUGS

    Amount: $473,046.00

    VIRAL PROLIFERATION REQUIRES THE INTERACTION OF VIRAL REGULATORY PROTEINS WITH THEIR COGNATE RECOGNITION SEQUENCESWITHIN THE VIRAL GENOME. THIS RESEARCH SEEKS TO IDENTIFY SMALL MOLECULES THAT WILL INT ...

    SBIR Phase II 1992 Department of Health and Human Services
  6. RANDOM RECEPTOR MIMITOPE LIBRARY

    Amount: $50,000.00

    MIMETIC DRUGS COMPRISE AN IMPORTANT PART OF THE PHARMACOPOEIA. THEY WORK BY BINDING TO RECEPTORS FOR HORMONES OR OTHER PHYSIOLOGICAL MEDIATORS AND EITHER BLOCK (ANTAGONIZE) OR MIMIC (AGONIZE) THE EFFE ...

    SBIR Phase I 1990 Department of Health and Human Services
  7. Recombinant HEV-Like Particles as a Potential Vaccine

    Amount: $77,900.00

    Hepatitis E virus (HEV) infections represent a major health problem in developing countries whereepidemics primarily affect young to middle-age adults. Although HEV does not lead to chronic hepatitiso ...

    SBIR Phase I 1994 Department of Health and Human Services
  8. Development of a Cell Culture System for HIV Infection

    Amount: $78,960.00

    Hepatitis E virus (HEV) is the major etiologic agent for enterically transmitted non-A, non-Bhepatitis. Hepatitis E represents more than half of the acute viral hepatitis cases occurring in developing ...

    SBIR Phase I 1994 Department of Health and Human Services
  9. DEVELOPMENT OF IMMUNOASSAY FOR HGV

    Amount: $93,852.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  10. HUMAN MONOCLONAL ANTIBODIES TO HLA-DR DETERMINANTS

    Amount: $50,000.00

    N/A

    SBIR Phase I 1985 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government